Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618.
Arnold SM, Moon J, Williamson SK, Atkins JN, Ou SH, LeBlanc M, Urba SG. Arnold SM, et al. Among authors: leblanc m. Invest New Drugs. 2011 Apr;29(2):352-9. doi: 10.1007/s10637-009-9348-z. Epub 2009 Nov 25. Invest New Drugs. 2011. PMID: 19937365 Free PMC article. Clinical Trial.
Extreme regression.
LeBlanc M, Moon J, Kooperberg C. LeBlanc M, et al. Biostatistics. 2006 Jan;7(1):71-84. doi: 10.1093/biostatistics/kxi041. Epub 2005 Jun 22. Biostatistics. 2006. PMID: 15972888
Adaptive risk group refinement.
LeBlanc M, Moon J, Crowley J. LeBlanc M, et al. Biometrics. 2005 Jun;61(2):370-8. doi: 10.1111/j.1541-0420.2005.020738.x. Biometrics. 2005. PMID: 16011683 Clinical Trial.
Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
Agrawal A, Moon J, Davis RK, Sakr WA, Giri SP, Valentino J, LeBlanc M, Truelson JM, Yoo GH, Ensley JF, Schuller DE; Southwest Oncology Group. Agrawal A, et al. Among authors: leblanc m. Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):1044-50. doi: 10.1001/archotol.133.10.1044. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17938330 Clinical Trial.
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G. Yoo GH, et al. Among authors: leblanc m. Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):869-74. doi: 10.1001/archoto.2009.122. Arch Otolaryngol Head Neck Surg. 2009. PMID: 19770418 Free PMC article. Clinical Trial.
1,305 results